Krankenanstalt Mutterhaus der Borromaerinnen
About Krankenanstalt Mutterhaus der Borromaerinnen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
5
University of Ulm
5
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
4
German CLL Study Group
3
University Hospital Schleswig-Holstein
3
European Organisation for Research and Treatment of Cancer - EORTC
2
Hoffmann-La Roche
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
University of Heidelberg Medical Center
2
Universität des Saarlandes
2
AGO Research GmbH
1
Clinical Trials at Krankenanstalt Mutterhaus der Borromaerinnen
During the past decade, Krankenanstalt Mutterhaus der Borromaerinnen conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on
average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
1999-02-01
Terminated
158
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
1999-04-01
2015-03-01
Completed
359
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Krankenanstalt Mutterhaus der Borromaerinnen" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "University of Ulm" with 5 trials
sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "German CLL Study Group" with 3 trials sponsored and "University Hospital Schleswig-Holstein"
with 3 trials sponsored. Other sponsors include 28 different institutions and
companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenanstalt Mutterhaus der Borromaerinnen"
#1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator and "Roche Pharma AG" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were
collaborators in the rest 40 trials.
Clinical Trials Conditions at Krankenanstalt Mutterhaus der Borromaerinnen
According to Clinical.Site data, the most researched conditions in "Krankenanstalt Mutterhaus der Borromaerinnen" are
"Lymphoma" (6 trials), "Acute Myeloid Leukemia" (4 trials), "Leukemia" (4 trials), "Acute Myeloid Leukemia (AML)" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Krankenanstalt Mutterhaus der Borromaerinnen" in a lesser frequency.
Clinical Trials Intervention Types at Krankenanstalt Mutterhaus der Borromaerinnen
Most popular intervention types in "Krankenanstalt Mutterhaus der Borromaerinnen" are "Drug" (47 trials), "Radiation" (16 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (12 trials), "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (10 trials), "vincristine sulfate" (10 trials) and "filgrastim" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenanstalt Mutterhaus der Borromaerinnen
The vast majority of trials in "Krankenanstalt Mutterhaus der Borromaerinnen" are
47 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Krankenanstalt Mutterhaus der Borromaerinnen
Currently, there are NaN active trials in "Krankenanstalt Mutterhaus der Borromaerinnen".
undefined are not yet recruiting,
10 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 27 completed trials in Krankenanstalt Mutterhaus der Borromaerinnen,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenanstalt Mutterhaus der Borromaerinnen, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Krankenanstalt Mutterhaus der Borromaerinnen
Krankenanstalt Mutterhaus der Borromaerinnen has several departments that took part in Clinical trials: "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" - 11 trials, "Klinikum Mutterhaus der Borromäerinnen, Innere Medizin I" - 2 trials
Departments List